The stock of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a huge mover today! The stock decreased 4.71% or $0.2 during the last trading session, reaching $4.05. About 60,919 shares traded. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has declined 28.97% since June 13, 2017 and is downtrending. It has underperformed by 41.54% the S&P500. Some Historical TNXP News: ; 21/03/2018 – Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL; 01/05/2018 – TONIX GETS IND CLEARANCE BY FDA FOR TNX-102 SL; 12/03/2018 Tonix Pharmaceuticals 4Q Loss/Shr 71c; 24/05/2018 – TONIX SAYS TONMYA STUDY RESULTS CONFIRMS 505B2 APPLICABILITY; 24/05/2018 – TONIX PHARMACEUTICALS HOLDING – PRELIMINARY AND UNAUDITED ADVERSE EVENT (AES) DATA FROM PK STUDY WERE GENERALLY AS EXPECTED; 14/05/2018 – Tonix Pharmaceuticals 1Q Loss/Shr 88c; 03/04/2018 – TONIX PHARMACEUTICALS ACHIEVES 50 PERCENT ENROLLMENT IN PHASE 3 TRIAL OF FDA-DESIGNATED BREAKTHROUGH THERAPY TONMYA® (CYCLOBENZAPRINE HCL SUBLINGUAL TABLETS) FOR THE TREATMENT OF PTSD; 22/04/2018 – DJ Tonix Pharmaceuticals Holding Corp, Inst Holders, 1Q 2018 (TNXP); 21/03/2018 – TONIX EXPANDS INTELLECTUAL PROPERTY PORTFOLIO FOR TNX-102 SL; 03/04/2018 – TNXP SEES TOPLINE DATA FOR TONMYA PHASE 3 IN 4Q 2018The move comes after 9 months negative chart setup for the $34.27 million company. It was reported on Jun, 13 by Barchart.com. We have $3.89 PT which if reached, will make NASDAQ:TNXP worth $1.37M less.
Among 10 analysts covering Internap Corp (NASDAQ:INAP), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Internap Corp had 19 analyst reports since August 22, 2015 according to SRatingsIntel. The stock has “Hold” rating by Craig Hallum on Friday, February 19. As per Saturday, August 22, the company rating was downgraded by TheStreet. The rating was downgraded by DA Davidson on Friday, September 25 to “Neutral”. The stock has “Buy” rating by Benchmark on Friday, August 4. On Friday, September 25 the stock rating was downgraded by Wells Fargo to “Market Perform”. Suntrust Robinson initiated Internap Corporation (NASDAQ:INAP) on Tuesday, November 24 with “Neutral” rating. The rating was upgraded by Stifel Nicolaus to “Buy” on Friday, March 10. The company was maintained on Wednesday, September 13 by Stifel Nicolaus. The firm has “Buy” rating by Stifel Nicolaus given on Friday, August 4. The rating was initiated by SunTrust on Tuesday, November 24 with “Neutral”. See Internap Corporation (NASDAQ:INAP) latest ratings:
09/03/2018 Broker: Craig Hallum Rating: Buy New Target: $22.0
More recent Internap Corporation (NASDAQ:INAP) news were published by: Nasdaq.com which released: “INAP Names James C. Keeley Chief Financial Officer” on June 11, 2018. Also Nasdaq.com published the news titled: “INAP to Present at RBC 2018 Global Datacenter and Connectivity Conference” on May 18, 2018. Nasdaq.com‘s news article titled: “INAP Transforms Its Global Network Through Ciena Collaboration” with publication date: May 21, 2018 was also an interesting one.
The stock decreased 1.95% or $0.22 during the last trading session, reaching $11.08. About 474,714 shares traded or 67.15% up from the average. Internap Corporation (NASDAQ:INAP) has declined 22.65% since June 13, 2017 and is downtrending. It has underperformed by 35.22% the S&P500. Some Historical INAP News: ; 14/05/2018 – INAP Announces Chief Financial Officer Transition; 30/04/2018 – Vivox Expands Partnership with INAP for Colocation and Performance IPTM Services at Boston Data Center; 11/04/2018 – GAMCO REPORTS 24.39% STAKE IN INTERNAP CORPORATION; 23/04/2018 – DJ Internap Corporation, Inst Holders, 1Q 2018 (INAP); 14/05/2018 – InterNAP Sats Robert M. Dennerlein Stepping Dn as Chief Fincl Officer; 08/03/2018 – InterNAP Sees FY Rev $320M-$330M; 03/05/2018 – INTERNAP CORP INAP.O SEES FY 2018 REVENUE $320 MLN TO $330 MLN; 30/05/2018 – World’s Largest Social Casino Games Company Selects INAP for Colocation and Performance IP™ Services at Santa Clara Data Ce; 12/03/2018 – InterNAP Network Services Corp. – An SEC probe disclosed in the 10-K filed a year ago (Mar-2017) was confirmed as ongoing (published 18-Jan) $INAP; 14/05/2018 – INAP SAYS DENNERLEIN STEPPING DOWN AS CFO
Internap Corporation operates as a technology well-known provider of Internet infrastructure services. The company has market cap of $218.62 million. It operates through two business divisions, Data Center and Network Services, and Cloud and Hosting Services. It currently has negative earnings. The Data Center and Network Services segment offers colocation services, including physical space within data centers and related services, such as power, interconnection, environmental controls, monitoring, and security; and Internet protocol connectivity services comprising its patented Performance IP and content delivery network services, IP routing hardware and software platforms, and Managed Internet Route Optimizer controllers.
Investors sentiment is 0 in 2018 Q1. Its the same as in 2017Q4. It is without change, as 1 investors sold Internap Corporation shares while 1 reduced holdings. only 0 funds opened positions while 0 raised stakes. 21,025 shares or 64.02% less from 58,432 shares in 2017Q4 were reported. Eidelman Virant Cap has invested 0.15% in Internap Corporation (NASDAQ:INAP). West Oak Ltd Liability Corporation stated it has 500 shares. Focused Wealth Management Incorporated stated it has 0% in Internap Corporation (NASDAQ:INAP).
Since May 23, 2018, it had 2 buys, and 0 sales for $27,103 activity. Shares for $2,703 were bought by Ramlall Richard on Wednesday, May 23. WILSON DEBORA J bought 2,500 shares worth $24,400.
More notable recent Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) news were published by: Globenewswire.com which released: “Tonix Pharmaceuticals to Present at the 2018 BIO International Convention” on May 30, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on June 06, 2018, Nasdaq.com published: “Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from …” on May 31, 2018. More interesting news about Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were released by: Nasdaq.com and their article: “Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology” published on May 23, 2018 as well as Nasdaq.com‘s news article titled: “Tonix Pharmaceuticals Reports Preliminary Results from a Phase 1 Pivotal Multiple-Dose Bridging Pharmacokinetic …” with publication date: May 24, 2018.
Analysts await Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) to report earnings on August, 13. They expect $-0.73 EPS, down 12.31% or $0.08 from last year’s $-0.65 per share. After $-0.88 actual EPS reported by Tonix Pharmaceuticals Holding Corp. for the previous quarter, Wall Street now forecasts -17.05% EPS growth.
Among 4 analysts covering Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tonix Pharmaceuticals Holding Corp. had 7 analyst reports since August 20, 2015 according to SRatingsIntel. Oppenheimer maintained the shares of TNXP in report on Thursday, August 20 with “Outperform” rating. The stock of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) earned “Buy” rating by Roth Capital on Friday, August 18. Cantor Fitzgerald upgraded the shares of TNXP in report on Thursday, June 2 to “Buy” rating. As per Wednesday, November 4, the company rating was initiated by Cantor Fitzgerald. On Thursday, November 9 the stock rating was maintained by Roth Capital with “Buy”. The firm earned “Buy” rating on Monday, June 26 by Aegis Capital.